| Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology A Olmos-Alonso, STT Schetters, S Sri, K Askew, R Mancuso, ... Brain 139 (3), 891-907, 2016 | 473 | 2016 |
| The tumour glyco-code as a novel immune checkpoint for immunotherapy E RodrÍguez, STT Schetters, Y van Kooyk Nature Reviews Immunology 18 (3), 204-211, 2018 | 387 | 2018 |
| The PD-1/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes F Dammeijer, M van Gulijk, EE Mulder, M Lukkes, L Klaase, ... Cancer cell 38 (5), 685-700. e8, 2020 | 370 | 2020 |
| Neuroinflammation: microglia and T cells get ready to tango STT Schetters, D Gomez-Nicola, JJ Garcia-Vallejo, Y Van Kooyk Frontiers in immunology 8, 294587, 2018 | 345 | 2018 |
| Transcriptional profiling of CD11c-positive microglia accumulating around amyloid plaques in a mouse model for Alzheimer's disease W Kamphuis, L Kooijman, S Schetters, M Orre, EM Hol Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1862 (10 …, 2016 | 185 | 2016 |
| Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells M Perdicchio, JM Ilarregui, MI Verstege, LAM Cornelissen, STT Schetters, ... Proceedings of the National Academy of Sciences 113 (12), 3329-3334, 2016 | 153 | 2016 |
| Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9 E Rodriguez, K Boelaars, K Brown, RJ Eveline Li, L Kruijssen, ... Nature communications 12 (1), 1270, 2021 | 146 | 2021 |
| Functional CD169 on macrophages mediates interaction with dendritic cells for CD8+ T cell cross-priming D van Dinther, H Veninga, S Iborra, EGF Borg, L Hoogterp, K Olesek, ... Cell reports 22 (6), 1484-1495, 2018 | 118 | 2018 |
| Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8+ T cells STT Schetters, WSP Jong, SK Horrevorts, LJW Kruijssen, S Engels, ... Acta biomaterialia 91, 248-257, 2019 | 87 | 2019 |
| Differential role of CCR2 in the dynamics of microglia and perivascular macrophages during prion disease D Gómez‐Nicola, STT Schetters, V Hugh Perry Glia 62 (7), 1041-1052, 2014 | 54 | 2014 |
| Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy STT Schetters, E Rodriguez, LJW Kruijssen, MHW Crommentuijn, L Boon, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 47 | 2020 |
| Mouse DC-SIGN/CD209a as target for antigen delivery and adaptive immunity STT Schetters, LJW Kruijssen, MHW Crommentuijn, H Kalay, J Ochando, ... Frontiers in immunology 9, 990, 2018 | 46 | 2018 |
| PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance M van Gulijk, A van Krimpen, S Schetters, M Eterman, M van Elsas, ... Science Immunology 8 (83), eabn6173, 2023 | 23 | 2023 |
| Immunological dynamics after subcutaneous immunization with a squalene‐based oil‐in‐water adjuvant STT Schetters, LJW Kruijssen, MHW Crommentuijn, H Kalay, ... The FASEB Journal 34 (9), 12406, 2020 | 17 | 2020 |
| Bacterial inclusion bodies function as vehicles for dendritic cell-mediated T cell responses STT Schetters, WSP Jong, LJW Kruijssen, ... Cellular & molecular immunology 17 (4), 415-417, 2020 | 15 | 2020 |
| Human CXCR5+PD‐1+ CD8 T cells in healthy individuals and patients with hematologic malignancies T Hofland, AWJ Martens, JAC van Bruggen, R de Boer, S Schetters, ... European journal of immunology 51 (3), 703-713, 2021 | 12 | 2021 |
| Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity STT Schetters, RJE Li, LJW Kruijssen, S Engels, M Ambrosini, ... Biomaterials 262, 120342, 2020 | 11 | 2020 |
| Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits E Rodriguez, K Boelaars, K Brown, K Madunić, T van Ee, F Dijk, J Verheij, ... Communications Biology 5 (1), 41, 2022 | 10 | 2022 |
| Immune involvement of the contralateral hemisphere in a glioblastoma mouse model MHW Crommentuijn, STT Schetters, SA Dusoswa, LJW Kruijssen, ... Journal for immunotherapy of cancer 8 (1), 2020 | 10 | 2020 |
| Chemically engineered glycan-modified cancer vaccines to mobilize skin dendritic cells S Duinkerken, RE Li, FJ van Haften, TD de Gruijl, F Chiodo, STT Schetters, ... Current Opinion in Chemical Biology 53, 167-172, 2019 | 9 | 2019 |
